A LAMA inhaler is a type of long-acting bronchodilator that opens your airways for 12 to 24 hours per dose. LAMA stands for Long-Acting Muscarinic Antagonist, and these inhalers are primarily prescribed as maintenance therapy for COPD, with one product also approved for asthma in the United States. They’re not rescue inhalers. Instead, they work slowly and steadily to keep airways relaxed over the course of a day.
How LAMA Inhalers Work
Your airways are lined with smooth muscle that tightens and relaxes based on signals from your nervous system. One of those signals comes from a chemical messenger called acetylcholine, which binds to receptors on the muscle and tells it to contract. In people with COPD or poorly controlled asthma, this tightening narrows the airways and makes breathing difficult.
A LAMA inhaler blocks acetylcholine from reaching those receptors. With the “squeeze” signal interrupted, the smooth muscle around your airways stays relaxed and the passages stay open. This improves airflow, reduces shortness of breath, and makes physical activity easier to tolerate. The effect builds over time rather than hitting all at once, which is why LAMAs are used daily for long-term control rather than for sudden breathing emergencies.
Common LAMA Medications
Several LAMA drugs are available, and the main difference between them is how often you take them. Tiotropium, umeclidinium, and glycopyrronium are all once-daily options. Aclidinium is taken twice daily. Each works through the same basic mechanism, but they come in different inhaler devices and may suit different people depending on coordination ability and breathing strength.
Tiotropium (sold as Respimat) is the most widely studied and is the only LAMA currently approved for both COPD and asthma in the U.S. The others are approved for COPD. Your doctor’s choice often comes down to which device you can use most effectively and whether you’re also taking other inhaled medications that might come packaged with a LAMA in a combination inhaler.
What Conditions They Treat
COPD is the primary reason LAMA inhalers are prescribed. Current treatment guidelines sort COPD patients into groups based on symptom severity and how often flare-ups (exacerbations) occur. People with milder symptoms and few flare-ups may start on a LAMA alone. Those with more symptoms typically begin on a LAMA combined with a LABA (a different type of long-acting bronchodilator that relaxes airways through a separate pathway). People with frequent or severe exacerbations may need triple therapy: a LAMA, a LABA, and an inhaled corticosteroid together.
For asthma, LAMAs play a narrower role. They’re added when asthma remains uncontrolled despite treatment with an inhaled corticosteroid and a LABA. In clinical trials, adding a LAMA to that combination reduced moderate and severe flare-ups by roughly 12% to 15%, with even greater reductions during winter months when exacerbations tend to spike. One set of trials found that adding a LAMA delayed the first severe asthma exacerbation by 56 days and cut the risk of a severe flare-up by 21%.
How LAMAs Differ From LABAs
Both LAMAs and LABAs are long-acting bronchodilators, but they open airways through completely different mechanisms. A LABA activates receptors that tell airway muscles to relax. A LAMA blocks the receptors that tell airway muscles to tighten. Because these two pathways are independent, using both together provides more airway opening than either one alone.
Head-to-head comparisons show that LAMAs and LABAs produce similar improvements in breathing test scores, breathlessness ratings, and quality-of-life measures. Neither class is clearly superior to the other when used alone. The real advantage comes from combining them, which is why LAMA/LABA combination inhalers are now standard for people with moderate to severe COPD symptoms.
Types of Inhaler Devices
LAMA medications are delivered through three main device types, and the choice of device matters more than many people realize. Getting the technique wrong means less medication reaches your lungs.
- Dry powder inhalers (DPIs) are breath-activated, meaning you trigger the dose simply by inhaling through the device. They’re compact and don’t require you to coordinate pressing a button while breathing in. However, they do require a strong enough inhalation to pull the powder deep into your lungs. Some older adults or people with very severe COPD can’t generate enough airflow, which reduces the dose they actually receive.
- Soft mist inhalers release medication as a slow-moving mist, giving you more time to coordinate your breath with the spray. They don’t need a propellant. The tradeoff is that they require some hand strength and dexterity to load and activate, and each dose needs two separate puffs.
- Pressurized metered-dose inhalers (pMDIs) are the classic “press and breathe” devices. They’re widely available but require good hand-breath coordination to use effectively.
If you find yourself struggling with one device type, ask about alternatives. The best inhaler is the one you can use correctly every time.
Side Effects
Because LAMAs block acetylcholine, their side effects reflect what happens when that chemical messenger is suppressed throughout the body, not just in the lungs. The most common complaint is dry mouth, which affects a noticeable number of users and can be persistent enough to be bothersome. Other possible effects include constipation, blurred vision, drowsiness, and difficulty urinating.
The urinary effects deserve particular attention. Acetylcholine helps the bladder muscle contract, so blocking it can lead to urinary retention, especially in men with an enlarged prostate. If you notice a weaker stream or difficulty emptying your bladder after starting a LAMA, that’s worth bringing up with your doctor.
Eye pressure is another concern. LAMAs can increase pressure inside the eye, which is a problem for people with narrow-angle glaucoma. If you have glaucoma or a history of elevated eye pressure, your doctor should know before prescribing a LAMA. For most people without these risk factors, the side effects are mild and manageable, and the breathing benefits significantly outweigh them.
What Daily Use Looks Like
Most LAMA inhalers are taken once a day, typically at the same time each morning. Aclidinium is the exception, requiring a dose in the morning and another in the evening. Because the effect builds gradually over days and weeks, you won’t feel an immediate dramatic difference the way you would with a rescue inhaler. Improvements in breathing, exercise tolerance, and quality of life become more apparent after consistent use over several weeks.
Missing doses reduces the steady bronchodilation that keeps your airways open, so daily consistency matters. If you’re using a LAMA as part of a combination (with a LABA or with both a LABA and an inhaled corticosteroid), these are often available in a single inhaler device, which simplifies the routine to one device, once a day.